Literature DB >> 2904534

Nasal continuous positive airway pressure in Pneumocystis carinii pneumonia.

S Kesten1, A S Rebuck.   

Abstract

10 cm H2O of nasal continuous positive airway pressure (CPAP) was applied in nine subjects with Pneumocystis carinii pneumonia and the acquired immunodeficiency syndrome, all of whom had presented with bilateral pulmonary infiltrates and hypoxaemia. The procedure was tolerated well by eight patients and none of the nine had complications. 20 minutes of nasal CPAP without supplemental oxygen increased mean PaO2 from 55.9 to 68.4 mm Hg and decreased the calculated alveolar-arterial oxygen gradient from 48.3 to 34.3 mm Hg. In one patient who was breathing oxygen at 4 litres per minute, PaO2 increased by 35 mm Hg. Nasal CPAP could be a useful method for augmenting oxygenation in P carinii pneumonia.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2904534     DOI: 10.1016/s0140-6736(88)90597-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  5 in total

1.  Non-invasive ventilation in acute respiratory failure.

Authors: 
Journal:  Thorax       Date:  2002-03       Impact factor: 9.139

2.  Non-invasive mechanical ventilation for acute respiratory failure.

Authors:  M W Elliott; M H Steven; G D Phillips; M A Branthwaite
Journal:  BMJ       Date:  1990-02-10

Review 3.  Aids and the lung. 6-- Management of respiratory failure in patients with the acquired immune deficiency syndrome and Pneumocystis carinii pneumonia.

Authors:  R F Miller; D M Mitchell
Journal:  Thorax       Date:  1990-02       Impact factor: 9.139

4.  Non-invasive mechanical ventilation for acute respiratory failure.

Authors:  D Bell; J F Riordan; M W McNicol; C Pratt; S Lam
Journal:  BMJ       Date:  1990-04-07

Review 5.  The use of non-invasive ventilation during acute respiratory failure due to pneumonia.

Authors:  Miquel Ferrer; Roberto Cosentini; Stefano Nava
Journal:  Eur J Intern Med       Date:  2012-03-28       Impact factor: 4.487

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.